Catalyst Wire Dossier Catalyst Wire Dossier

RVT-101

intepirdine · Axovant Sciences Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RVT-101, covering 2018-12-05 to 2018-12-05. Get the full timeline:

Most recent: Clinical Trial Update: Study Evaluating Intepirdine (RVT-101) in Subjects With Mild to Moderate Alzheimer's Disease on Donepezil: MINDSET Study [Phase 3]

See pricing